AS
TAK icon

Altshuler Shaham’s Takeda Pharmaceutical TAK Stock Holding History

Altshuler Shaham’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-84,739
Closed -$1.21M – 365
2023
Q4 		$1.21M Sell
84,739
-51,609
-38% -$732K 0.07% 35
2023
Q3 		$2.11M Hold
136,348
– – 0.06% 30
2023
Q2 		$2.14M Hold
136,348
– – 0.04% 34
2023
Q1 		$2.25M Buy
+136,348
New +$2.17M 0.05% 32

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Altshuler Shaham's TAK Position: Q1 2024 in Review

Altshuler Shaham sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 84,739 shares — an estimated $1.21M sold.

Altshuler Shaham first reported a position in TAK in Q1 2023 and held it in 4 quarters. The position peaked at $2.25M in Q1 2023. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Altshuler Shaham reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Altshuler Shaham sold 84,739 Takeda Pharmaceutical shares in Q1 2024, an estimated $1.21M.
  • Altshuler Shaham first reported a position in Takeda Pharmaceutical in Q1 2023 and held it in 4 quarters.
  • Altshuler Shaham's Takeda Pharmaceutical position peaked at $2.25M in Q1 2023.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Altshuler Shaham's 13F filing for Q1 2024, filed 15 May 2024.